Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Cytosorbents (CTSO) Leases (2018 - 2025)

Cytosorbents' Leases history spans 8 years, with the latest figure at $10.9 million for Q4 2025.

  • Quarterly results put Leases at $10.9 million for Q4 2025, down 5.1% from a year ago — trailing twelve months through Dec 2025 was $10.9 million (down 5.1% YoY), and the annual figure for FY2025 was $10.9 million, down 5.1%.
  • Leases for Q4 2025 was $10.9 million at Cytosorbents, down from $11.1 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $13.7 million in Q3 2021 to a low of $923960.0 in Q1 2021.
  • The 5-year median for Leases is $12.1 million (2023), against an average of $11.7 million.
  • Peak annual rise in Leases hit 1328.29% in 2022, while the deepest fall reached 6.28% in 2022.
  • Year by year, Leases stood at $13.4 million in 2021, then dropped by 6.11% to $12.6 million in 2022, then dropped by 4.32% to $12.1 million in 2023, then fell by 4.54% to $11.5 million in 2024, then fell by 5.1% to $10.9 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $10.9 million, $11.1 million, and $11.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.